Geode Capital Management LLC lowered its stake in shares of LivaNova PLC (NASDAQ:LIVN) by 0.1% during the first quarter, Holdings Channel reports. The firm owned 349,569 shares of the company’s stock after selling 335 shares during the period. Geode Capital Management LLC’s holdings in LivaNova PLC were worth $17,132,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of LivaNova PLC by 4.5% in the first quarter. Vanguard Group Inc. now owns 777,356 shares of the company’s stock valued at $38,098,000 after buying an additional 33,645 shares during the period. Thrivent Financial For Lutherans raised its position in shares of LivaNova PLC by 8.7% in the first quarter. Thrivent Financial For Lutherans now owns 8,150 shares of the company’s stock valued at $399,000 after buying an additional 650 shares during the period. Bellevue Group AG purchased a new position in shares of LivaNova PLC during the first quarter valued at approximately $3,146,000. Advantus Capital Management Inc raised its position in shares of LivaNova PLC by 3.3% in the first quarter. Advantus Capital Management Inc now owns 5,551 shares of the company’s stock valued at $272,000 after buying an additional 176 shares during the period. Finally, FMR LLC raised its position in shares of LivaNova PLC by 74.9% in the first quarter. FMR LLC now owns 4,817,815 shares of the company’s stock valued at $236,118,000 after buying an additional 2,063,196 shares during the period. Hedge funds and other institutional investors own 72.76% of the company’s stock.

LivaNova PLC (NASDAQ LIVN) opened at 61.63 on Tuesday. The stock’s 50 day moving average price is $59.31 and its 200 day moving average price is $51.85. LivaNova PLC has a 12 month low of $40.83 and a 12 month high of $63.21. The company’s market capitalization is $3.01 billion.

LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings data on Wednesday, May 3rd. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.03. The business had revenue of $285.10 million for the quarter. LivaNova PLC had a negative net margin of 0.92% and a positive return on equity of 8.77%. Equities research analysts anticipate that LivaNova PLC will post $3.11 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “LivaNova PLC (LIVN) Position Cut by Geode Capital Management LLC” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/07/18/livanova-plc-livn-position-cut-by-geode-capital-management-llc.html.

In other LivaNova PLC news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $60.80, for a total transaction of $60,800.00. Following the transaction, the director now owns 57,437 shares of the company’s stock, valued at $3,492,169.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Hugh M. Morrison sold 3,215 shares of the stock in a transaction that occurred on Friday, May 5th. The stock was sold at an average price of $55.89, for a total transaction of $179,686.35. Following the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $111,780. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,215 shares of company stock worth $298,976. 0.28% of the stock is currently owned by insiders.

About LivaNova PLC

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.